• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Financial Officer Armbrister Jeffrey Brian covered exercise/tax liability with 393 shares, decreasing direct ownership by 3% to 11,439 units (SEC Form 4)

    9/18/25 4:55:55 PM ET
    $HLNE
    Investment Managers
    Finance
    Get the next $HLNE alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Armbrister Jeffrey Brian

    (Last) (First) (Middle)
    C/O HAMILTON LANE INCORPORATED
    110 WASHINGTON STREET, SUITE 1300

    (Street)
    CONSHOHOCKEN PA 19428

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Hamilton Lane INC [ HLNE ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Financial Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    09/16/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock 09/16/2025 F(1) 393 D $146.53 11,439(2) D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Performance Stock (3) 09/16/2025 A 2,033 (3) (3) Class A Common Stock 2,033 $0 2,033 D
    Performance Stock (4) (4) (4) Class A Common Stock 4,348 4,348 D
    Performance Stock (5) (5) (5) Class A Common Stock 13,044 13,044 D
    Explanation of Responses:
    1. Shares delivered to the issuer for the payment of withholding taxes due upon the vesting of previously granted restricted stock awards.
    2. Includes unvested restricted stock granted under the Issuer's 2017 Equity Incentive Plan.
    3. Each share of performance stock represents a contingent right to receive one share of Class A common stock of the Issuer. The performance stock vests at the end of the performance period if the Issuer's Class A common stock achieves a specified growth rate of TSR over the performance period. The performance period of the performance stock ends on September 16, 2030.
    4. Each share of performance stock represents a contingent right to receive one share of Class A common stock. The performance stock vests upon the Issuer's Class A common stock achieving a specified price per share. The performance period of the performance stock ends on September 16, 2031.
    5. Each share of performance stock represents a contingent right to receive one share of Class A common stock. The performance stock vests upon the Issuer's Class A common stock achieving a specified price per share. The performance period of the performance stock ends on September 16, 2029.
    Remarks:
    /s/ Lauren Platko, attorney-in-fact 09/18/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $HLNE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HLNE

    DatePrice TargetRatingAnalyst
    12/11/2025$166.00Buy
    UBS
    11/6/2025$165.00Neutral → Buy
    Goldman
    10/14/2025$181.00Perform → Outperform
    Oppenheimer
    10/13/2025$150.00Mkt Perform → Outperform
    Keefe Bruyette
    10/3/2025$150.00Outperform
    BMO Capital Markets
    9/18/2025$162.00Sell → Neutral
    Goldman
    5/15/2025Outperform → Perform
    Oppenheimer
    1/21/2025$186.00Perform → Outperform
    Oppenheimer
    More analyst ratings

    $HLNE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Chief Executive Officer Delgado-Moreira Juan bought $1,042,832 worth of shares (8,000 units at $130.35), increasing direct ownership by 0.61% to 1,314,447 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    11/10/25 8:20:49 PM ET
    $HLNE
    Investment Managers
    Finance

    New insider Mcallister Margaret Anne claimed ownership of 59,006 shares and claimed ownership of 300,000 units of Class B Common Stock (SEC Form 3)

    3 - Hamilton Lane INC (0001433642) (Issuer)

    9/18/25 5:03:07 PM ET
    $HLNE
    Investment Managers
    Finance

    Director Sexton O Griffith was granted 1,331 shares, increasing direct ownership by 38% to 4,852 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    9/18/25 5:01:35 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    SEC Filings

    View All

    SEC Form 10-Q filed by Hamilton Lane Incorporated

    10-Q - Hamilton Lane INC (0001433642) (Filer)

    2/3/26 4:18:01 PM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Hamilton Lane INC (0001433642) (Filer)

    2/3/26 7:00:09 AM ET
    $HLNE
    Investment Managers
    Finance

    SEC Form 10-Q filed by Hamilton Lane Incorporated

    10-Q - Hamilton Lane INC (0001433642) (Filer)

    11/4/25 4:16:24 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Chief Executive Officer Delgado-Moreira Juan bought $1,042,832 worth of shares (8,000 units at $130.35), increasing direct ownership by 0.61% to 1,314,447 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    11/10/25 8:20:49 PM ET
    $HLNE
    Investment Managers
    Finance

    Co-Chief Executive Officer Delgado-Moreira Juan bought $105,950 worth of shares (525 units at $201.81) (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    11/13/24 4:31:06 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HAMILTON LANE INCORPORATED REPORTS THIRD QUARTER FISCAL 2026 RESULTS

    CONSHOHOCKEN, Penn., Feb. 3, 2026 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the third fiscal quarter ended December 31, 2025. The Company issued a full detailed presentation of its third quarter fiscal 2026 results, which can be accessed on the Company's Shareholders website at https://shareholders.hamiltonlane.com/. Dividend Hamilton Lane has declared a quarterly dividend of $0.54 per share of Class A common stock to record holders at the close of business on March 20, 2026 that will be paid on April 6, 2026. The target full-year dividend of $2.16 represents a 10% increase from the prior fiscal year

    2/3/26 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Closes on Nearly $2 Billion in Infrastructure Opportunities Fund II and Related Vehicles, Tripling Size of Predecessor Fund

    IOF II closed on over $1.5 billion of capital commitments, with nearly $400 million of additional capital committed alongside the Fund in related vehicles, representing almost $2 billion in total commitmentsThe Fund and related vehicles are more than three times larger than predecessor vehicle and well exceeded its $1.25 billion targetCONSHOHOCKEN, Pa., Feb. 2, 2026 /PRNewswire/ -- Leading global private markets investment management firm Hamilton Lane (NASDAQ:HLNE) today announced the final closing of the Hamilton Lane Infrastructure Opportunities Fund II ("IOF II" or "the Fund"), with $1.5 billion closed in the Fund and another nearly $400 million invested alongside the Fund in related veh

    2/2/26 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    The Drive to Build Better Client Portfolios Fuels Interest in Private Markets: Hamilton Lane 2026 Global Private Wealth Survey

    Allocations to private markets continue to rise, with Venture Capital & Growth emerging as the leading strategy in 2026Vast majority of respondents do not view private markets as riskier than public markets, with 83% classifying the risk as similar or viewing the reward as higher          The survey polled 390 financial advisors across the Americas, Europe, the Middle East and Asia-Pacific CONSHOHOCKEN, Pa., Jan. 28, 2026 /PRNewswire/ -- In 2026, private wealth investors plan to increase allocations to private market investments, according to insights from 390 advisors surveyed in leading global private markets firm Hamilton Lane's (NASDAQ:HLNE) 2026 Global Private Wealth Survey.

    1/28/26 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UBS resumed coverage on Hamilton Lane with a new price target

    UBS resumed coverage of Hamilton Lane with a rating of Buy and set a new price target of $166.00

    12/11/25 9:09:19 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane upgraded by Goldman with a new price target

    Goldman upgraded Hamilton Lane from Neutral to Buy and set a new price target of $165.00

    11/6/25 8:41:24 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Hamilton Lane from Perform to Outperform and set a new price target of $181.00

    10/14/25 8:37:36 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/13/24 9:56:40 PM ET
    $HLNE
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/12/24 3:55:46 PM ET
    $HLNE
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/4/24 11:53:29 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Financials

    Live finance-specific insights

    View All

    HAMILTON LANE INCORPORATED REPORTS THIRD QUARTER FISCAL 2026 RESULTS

    CONSHOHOCKEN, Penn., Feb. 3, 2026 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the third fiscal quarter ended December 31, 2025. The Company issued a full detailed presentation of its third quarter fiscal 2026 results, which can be accessed on the Company's Shareholders website at https://shareholders.hamiltonlane.com/. Dividend Hamilton Lane has declared a quarterly dividend of $0.54 per share of Class A common stock to record holders at the close of business on March 20, 2026 that will be paid on April 6, 2026. The target full-year dividend of $2.16 represents a 10% increase from the prior fiscal year

    2/3/26 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Guardian unveils "The Year Ahead," revealing how 2026's major financial themes will shape Americans' financial future

    Inaugural report empowers individuals to navigate uncertainty, identify emerging opportunities, and plan holistically across their financial lives NEW YORK, Jan. 20, 2026 /PRNewswire/ -- As headlines and data often paint a conflicting economic picture, The Guardian Life Insurance Company of America® (Guardian) has issued Guardian Wealth Insights: The Year Ahead, an outlook designed to help Americans make sense of the financial opportunities and challenges in 2026. Read Guardian Wealth Insights: The Year Ahead here From navigating megatrends like inflation and regulatory change

    1/20/26 9:30:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated to Announce Third Quarter Fiscal 2026 Results on February 3, 2026

    CONSHOHOCKEN, Pa., Jan. 13, 2026 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the third fiscal quarter ended December 31, 2025 before the market opens on Tuesday, February 3, 2026. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on February 3 to discuss the results for the third fiscal quarter. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by  clicking here (https://shareholders.hamiltonlane.com/) at least

    1/13/26 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Leadership Updates

    Live Leadership Updates

    View All

    Hamilton Lane and Guardian Announce Long-Term Strategic Partnership

    CONSHOHOCKEN, Pa. and NEW YORK, Nov. 3, 2025 /PRNewswire/ -- Leading private markets firm Hamilton Lane (NASDAQ:HLNE) and The Guardian Life Insurance Company of America® ("Guardian"), one of the nation's largest life insurers and a leading provider of employee benefits, today announced an innovative, long-term strategic partnership. Through this partnership, Hamilton Lane will manage Guardian's existing private equity portfolio of nearly $5 billion. Guardian will also commit to invest approximately $500 million per year in private equity for the next 10 years through Hamilton Lane. This commitment maintains Guardian's typical annual contribution to the asset class and supports its general a

    11/3/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Cosette Pharmaceuticals Appoints Jeff Neubig as Vice President, Quality and Regulatory Affairs

    -- Experienced Industry Leader to drive Cosette's Best-in-Class Quality Organization and facilitate Regulatory Approvals -- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has appointed Jeff Neubig as Vice President, Quality and Regulatory Affairs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250630266171/en/Jeff Neubig, VP, Quality & Regulatory Affairs, Cosette Pharmaceuticals In this critical role, Jeff will lead Cosette's best-in-class quality and regulatory affairs organizations, maintaining the company's rigorous quality standards and further establishing Co

    6/30/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

    Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide. Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future. "I

    4/23/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance